Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Breast Neoplasms"" wg kryterium: Temat


Tytuł:
Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort.
Autorzy:
Masuda N; Department of Surgery, Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan. Electronic address: .
Ono M; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Mukohara T; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Yasojima H; Department of Surgery, Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan.
Shimoi T; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Kobayashi K; Department of Breast Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Harano K; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Mizutani M; Department of Surgery, Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan.
Tanioka M; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Takahashi S; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Kogawa T; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Suzuki T; Japan and Asia Clinical Development Department, Oncology Business Group, Eisai Co., Ltd., Tokyo, Japan.
Okumura S; Japan and Asia Clinical Development Department, Oncology Business Group, Eisai Co., Ltd., Tokyo, Japan.
Takase T; Clinical Data Science Department, Medicine Development Center, Eisai Co., Ltd., Tokyo, Japan.
Nagai R; Clinical Data Science Department, Medicine Development Center, Eisai Co., Ltd., Tokyo, Japan.
Semba T; Tsukuba Research Department, Oncology Business Group, Eisai Co., Ltd., Ibaraki, Japan.
Zhao ZM; Translational Science, Oncology Business Group, Eisai Inc., Nutley, NJ, USA.
Ren M; Biostats, Oncology Business Group, Eisai Inc., Nutley, NJ, USA.
Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Pokaż więcej
Źródło:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jun; Vol. 168, pp. 108-118. Date of Electronic Publication: 2022 Apr 29.
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/drug therapy
Breast Neoplasms*/pathology
Furans*/adverse effects
Ketones*/adverse effects
Cohort Studies ; Drug Compounding ; Febrile Neutropenia ; Female ; Humans ; Liposomes ; Triple Negative Breast Neoplasms/drug therapy
Czasopismo naukowe
Tytuł:
Analysis of pathogenic variants in BRCA1 and BRCA2 genes using next-generation sequencing in women with triple negative breast cancer from South India.
Autorzy:
Rajagopal T; Cancer Genomics Laboratory, Department of Biotechnology, School of Chemical and Biotechnology, SASTRA - Deemed University, Thanjavur, 613 401, India.
Seshachalam A; Department of Medical and Paediatric Oncology, Dr.G.V.N Cancer Institute, Singarathope, Trichy, 620 008, India.
Jothi A; Department of Bioinformatics, School of Chemical and Biotechnology, SASTRA - Deemed University, Thanjavur, 613 401, India.
Rathnam KK; Department of Hemato Oncology - Medical Oncology and Bone Marrow Transplantation, Meenakshi Mission Hospital & Research Centre, Madurai, 625 107, India.
Talluri S; Dana Farber Cancer Institute, Boston, MA, 02215, USA.; Veterans Administration Boston Healthcare System, West Roxbury, MA, 02132, USA.
Venkatabalasubranian S; Department of Genetic Engineering, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur Campus, Chennai, Tamil Nadu, 603 203, India.
Dunna NR; Cancer Genomics Laboratory, Department of Biotechnology, School of Chemical and Biotechnology, SASTRA - Deemed University, Thanjavur, 613 401, India. .
Pokaż więcej
Źródło:
Molecular biology reports [Mol Biol Rep] 2022 Apr; Vol. 49 (4), pp. 3025-3032. Date of Electronic Publication: 2022 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
BRCA1 Protein*/genetics
BRCA2 Protein*/genetics
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/pathology
Breast Neoplasms/genetics ; Female ; Genes, BRCA2 ; Genetic Predisposition to Disease ; Germ-Line Mutation/genetics ; High-Throughput Nucleotide Sequencing ; Humans ; Ovarian Neoplasms/genetics
Czasopismo naukowe
Tytuł:
A clinical trial to compare a 3D-printed bolus with a conventional bolus with the aim of reducing cardiopulmonary exposure in postmastectomy patients with volumetric modulated arc therapy.
Autorzy:
Zhang Y; Department of Radiation Oncology, Jiangxi Cancer Hospital of Nanchang University, Nanchang, PR China.
Huang Y; Department of Radiation Oncology, Jiangxi Cancer Hospital of Nanchang University, Nanchang, PR China.
Ding S; Department of Radiation Oncology, Jiangxi Cancer Hospital of Nanchang University, Nanchang, PR China.
Liang J; Department of Radiation Oncology, Jiangxi Cancer Hospital of Nanchang University, Nanchang, PR China.
Kuang J; School of Public Health, Nanchang University, Nanchang, PR China.
Mao Q; Department of Radiation Oncology, Jiangxi Cancer Hospital of Nanchang University, Nanchang, PR China.
Ying W; Department of Radiation Oncology, Jiangxi Cancer Hospital of Nanchang University, Nanchang, PR China.
Shu Y; Department of Radiation Oncology, Jiangxi Cancer Hospital of Nanchang University, Nanchang, PR China.
Li J; Department of Radiation Oncology, Jiangxi Cancer Hospital of Nanchang University, Nanchang, PR China.; Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma Nanchang, Nanchang, PR China.; Medical College of Nanchang University, Nanchang, PR China.
Jiang C; Department of Radiation Oncology, Jiangxi Cancer Hospital of Nanchang University, Nanchang, PR China.; Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma Nanchang, Nanchang, PR China.; Medical College of Nanchang University, Nanchang, PR China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2022 Feb; Vol. 11 (4), pp. 1037-1047. Date of Electronic Publication: 2021 Dec 23.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/radiotherapy
Breast Neoplasms*/surgery
Radiotherapy, Intensity-Modulated*/adverse effects
Radiotherapy, Intensity-Modulated*/methods
Female ; Humans ; Mastectomy ; Organs at Risk ; Printing, Three-Dimensional ; Radiation Pneumonitis/etiology ; Radiotherapy Dosage ; Unilateral Breast Neoplasms/radiotherapy ; Unilateral Breast Neoplasms/surgery
Czasopismo naukowe
Tytuł:
Accelerating progress to innovation for patients: Trial design and risk stratification.
Autorzy:
Regan MM; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA USA. Electronic address: .
Pokaż więcej
Źródło:
Breast (Edinburgh, Scotland) [Breast] 2022 Mar; Vol. 62 Suppl 1, pp. S80-S83. Date of Electronic Publication: 2021 Nov 20.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/drug therapy
Clinical Trials as Topic*
Diffusion of Innovation*
Chemotherapy, Adjuvant ; Female ; Humans ; Neoadjuvant Therapy/methods ; Research Design ; Risk Assessment ; Triple Negative Breast Neoplasms/drug therapy
Czasopismo naukowe
Tytuł:
Invasive Pleomorphic Lobular Carcinoma of The Male Breast: A Rare Diagnosis with Radiologic-Pathologic Correlation.
Autorzy:
Costa M; Serviço de Radiologia. Centro Hospitalar Universitário de Lisboa Central. Lisboa. Portugal.
Costeira B; Serviço de Cirurgia Geral. Instituto Português de Oncologia de Lisboa Francisco Gentil. Lisboa. Portugal.
Fonseca R; Serviço de Anatomia Patológica. Instituto Português de Oncologia de Lisboa Francisco Gentil. Lisboa. Portugal.
Maques JC; Serviço de Radiologia. Instituto Português de Oncologia de Lisboa Francisco Gentil. Lisboa. Portugal.
Pokaż więcej
Źródło:
Acta medica portuguesa [Acta Med Port] 2022 Nov 02; Vol. 35 (11), pp. 840-844. Date of Electronic Publication: 2022 Mar 07.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Carcinoma, Lobular*/diagnostic imaging
Carcinoma, Lobular*/pathology
Breast Neoplasms, Male*/diagnostic imaging
Breast Neoplasms*/pathology
Female ; Male ; Humans
Czasopismo naukowe
Tytuł:
Implication and Influence of Multigene Panel Testing with Genetic Counseling in Korean Patients with BRCA1/2 Mutation-Negative Breast Cancer.
Autorzy:
Park JS; Hereditary Cancer Clinic, Cancer Prevention Center, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Shin S; Hereditary Cancer Clinic, Cancer Prevention Center, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
Lee YJ; Division of Nursing, Severance Hospital, Seoul, Korea.
Lee ST; Hereditary Cancer Clinic, Cancer Prevention Center, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
Nam EJ; Hereditary Cancer Clinic, Cancer Prevention Center, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Department of Obstetrics and Gynecology, Institute of Women's Life Medical Science, Women's Cancer Clinic, Yonsei University College of Medicine, Seoul, Korea.
Han JW; Hereditary Cancer Clinic, Cancer Prevention Center, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea.
Lee SH; Division of Nursing, Severance Hospital, Seoul, Korea.
Kim TI; Hereditary Cancer Clinic, Cancer Prevention Center, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Park HS; Hereditary Cancer Clinic, Cancer Prevention Center, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2022 Oct; Vol. 54 (4), pp. 1099-1110. Date of Electronic Publication: 2021 Nov 17.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*
BRCA2 Protein/*genetics
Adult ; BRCA1 Protein/genetics ; Female ; Genetic Counseling ; Genetic Predisposition to Disease ; Humans ; Mutation ; Republic of Korea
Czasopismo naukowe
Tytuł:
Lumpectomy followed by radiation improves survival in HER2 positive and triple-negative breast cancer with high tumor-infiltrating lymphocytes compared to mastectomy alone.
Autorzy:
Mouabbi JA; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Chand M; Ascension St John Hospital, Detroit, MI, USA.
Asghar IA; Ascension St John Hospital, Detroit, MI, USA.
Sakhi R; Ascension St John Hospital, Detroit, MI, USA.
Ockner D; Ascension St John Hospital, Detroit, MI, USA.
Dul CL; Ascension St John Hospital, Detroit, MI, USA.
Hadid T; Ascension St John Hospital, Detroit, MI, USA.
Aref A; Ascension St John Hospital, Detroit, MI, USA.
Rimawi MF; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Hoyos V; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2021 Jul; Vol. 10 (14), pp. 4790-4795. Date of Electronic Publication: 2021 Jun 03.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Breast Neoplasms*/chemistry
Breast Neoplasms*/immunology
Breast Neoplasms*/mortality
Breast Neoplasms*/therapy
Lymphocytes, Tumor-Infiltrating*
Mastectomy, Segmental*/mortality
Receptor, ErbB-2*
Adult ; Age Factors ; Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Combined Modality Therapy/methods ; Combined Modality Therapy/mortality ; Disease-Free Survival ; Female ; Humans ; Kaplan-Meier Estimate ; Mastectomy/mortality ; Middle Aged ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Radiotherapy/mortality ; Retrospective Studies ; Time Factors ; Triple Negative Breast Neoplasms/chemistry ; Triple Negative Breast Neoplasms/immunology ; Triple Negative Breast Neoplasms/mortality ; Triple Negative Breast Neoplasms/therapy
Czasopismo naukowe
Tytuł:
Topical application of a cream containing nanoparticles with vitamin E for radiodermatitis prevention in women with breast cancer: A randomized, triple-blind, controlled pilot trial.
Autorzy:
Queiroz Schmidt FM; Federal Institute for Education, Science, and Technology of the South of Minas Gerais, (Instituto Federal de Educação, Ciência e Tecnologia do Sul de Minas Gerais- IFSULDEMINAS), 394, Penha Street, Penha II, 37903-358, Passos, Minas Gerais, Brazil. Electronic address: .
Serna González CV; Graduate Program in Adult Health Nursing at the School of Nursing of the University of Sao Paulo, (Universidade de Sao Paulo, Escola de Enfermagem-EEUSP), 419, Doctor Enéas de Carvalho Aguiar Avenue, Cerqueira César, 05403-000, Sao Paulo, Sao Paulo, Brazil. Electronic address: .
Mattar RC; Cancer Regional Hospital, Holy Mercy Hospital of Passos, (Hospital Regional de Câncer, Santa Casa de Misericórdia de Passos), José Merchioratto Street, Santa Casa, 37904-022, Passos, Minas Gerais, Brazil. Electronic address: .
Lopes LB; Pharmacology Department, Biomedical Sciences Institute, University of São Paulo, Brazil (Universidade de São Paulo, Instituto de Ciências Biomédicas), 1524, Professor Lineu Prestes Avenue, Butantã, 05508-000, Sao Paulo, Sao Paulo, Brazil. Electronic address: .
Santos MF; Cell and Developmental Biology Department, Institute of Biomedical Sciences, University of São Paulo, (Universidade de São Paulo, Instituto de Ciências Biomédicas), 1524, Professor Lineu Prestes Avenue, Butantã, 05508-000, Sao Paulo, Sao Paulo, Brazil. Electronic address: .
Santos VLCG; Department of Medical-Surgical Nursing at the School of Nursing of the University of Sao Paulo, Brazil (Universidade de Sao Paulo, Escola de Enfermagem-EEUSP), 419, Doctor Enéas de Carvalho Aguiar Avenue, Cerqueira César, 05403-000, Sao Paulo, Sao Paulo, Brazil. Electronic address: .
Pokaż więcej
Źródło:
European journal of oncology nursing : the official journal of European Oncology Nursing Society [Eur J Oncol Nurs] 2022 Dec; Vol. 61, pp. 102230. Date of Electronic Publication: 2022 Oct 29.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Radiodermatitis*/prevention & control
Breast Neoplasms*/drug therapy
Breast Neoplasms*/radiotherapy
Nanoparticles*
Adult ; Humans ; Female ; Vitamin E/therapeutic use ; Pilot Projects ; Antioxidants/therapeutic use ; Quality of Life
Czasopismo naukowe
Tytuł:
The impact of the SARS-COV-2 pandemic on the quality of breast cancer care in EUSOMA-certified breast centres.
Autorzy:
van Dam P; Multidisciplinary Oncologic Center, Antwerp University Hospital, Edegem, Belgium. Electronic address: .
Tomatis M; European Society of Breast Cancer Specialists (EUSOMA), Florence, Italy.
Ponti A; European Society of Breast Cancer Specialists (EUSOMA), Florence, Italy; CPO Piemonte, Turin, Italy.
Marotti L; European Society of Breast Cancer Specialists (EUSOMA), Florence, Italy.
Aristei C; Radiation Oncology Section, Department of Medicine and Surgery, University of Perugia and Perugia General Hospital Sant'Andrea delle Fratte Perugia, Italy.
Biganzoli L; 'Sandro Pitigliani' Department of Medical Oncology, Hospital of Prato, Prato, Italy.
Cardoso MJ; European Society of Breast Cancer Specialists (EUSOMA), Florence, Italy; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.
Cheung KL; European Society of Breast Cancer Specialists (EUSOMA), Florence, Italy; Academic Unit for Translational Medical Sciences, School of Medicine University of Nottingham, Royal Derby Hospital Centre, UK.
Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Italy.
De Vries J; University Medical Center Groeningen, the Netherlands.
Santini D; Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy.
Sardanelli F; Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy; Unit of Radiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.
Rubio IT; Breast Surgical Oncology, Clinica Universidad de Navarra, Madrid, Cancer Center Universidad de Navarra, Spain.
Pokaż więcej
Corporate Authors:
Eusoma Working Group
Źródło:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Dec; Vol. 177, pp. 72-79. Date of Electronic Publication: 2022 Oct 12.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/therapy
Breast Neoplasms*/pathology
COVID-19*
Humans ; Female ; Pandemics ; SARS-CoV-2 ; COVID-19 Testing
Czasopismo naukowe
Tytuł:
Tumor-promoting aftermath post-chemotherapy: A focus on breast cancer.
Autorzy:
Famta P; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
Shah S; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
Jain N; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
Kumar KC; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
Bagasariya D; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
Khatri DK; Department of Biological Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
Raghuvanshi RS; Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Government of India, India.
Singh SB; Department of Biological Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
Srivastava S; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India. Electronic address: .
Pokaż więcej
Źródło:
Life sciences [Life Sci] 2022 Dec 01; Vol. 310, pp. 121125. Date of Electronic Publication: 2022 Oct 25.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Triple Negative Breast Neoplasms*/pathology
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Breast Neoplasms*/drug therapy
Humans ; Female ; Phosphatidylinositol 3-Kinases ; Neoplasm Recurrence, Local/drug therapy ; Epithelial-Mesenchymal Transition ; Cell Line, Tumor ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Varying outcomes of triple-negative breast cancer in different age groups-prognostic value of clinical features and proliferation.
Autorzy:
Vihervuori H; Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 20510, Turku, Finland.
Korpinen K; Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 20510, Turku, Finland.
Autere TA; Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 20510, Turku, Finland.
Repo H; Department of Pathology, Central Hospital of Central Finland, Jyväskylä, Finland.
Talvinen K; Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 20510, Turku, Finland.
Kronqvist P; Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 20510, Turku, Finland. .; Department of Pathology, Turku University Hospital, Turku, Finland. .
Pokaż więcej
Źródło:
Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Dec; Vol. 196 (3), pp. 471-482. Date of Electronic Publication: 2022 Oct 19.
Typ publikacji:
Journal Article
MeSH Terms:
Triple Negative Breast Neoplasms*
Breast Neoplasms*
Middle Aged ; Humans ; Female ; Prognosis ; Geminin ; Ki-67 Antigen ; Cell Proliferation ; Biomarkers, Tumor
Czasopismo naukowe
Tytuł:
ASO Visual Abstract: Long-Term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement.
Autorzy:
Cobb AN; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Diao K; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Teshome M; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lucci A; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ueno NT; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Stauder M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Layman RM; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kuerer HM; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Woodward WA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sun SX; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. .; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. .
Pokaż więcej
Źródło:
Annals of surgical oncology [Ann Surg Oncol] 2022 Dec; Vol. 29 (Suppl 3), pp. 620-621.
Typ publikacji:
Journal Article
MeSH Terms:
Inflammatory Breast Neoplasms*
Breast Neoplasms*
Humans ; Female ; Lymphatic Metastasis ; Lymph Nodes/surgery
Czasopismo naukowe
Tytuł:
Breast cancer recurrence: factors impacting occurrence and survival.
Autorzy:
Courtney D; Department of Surgery, National University of Ireland, Galway, H91YR71, Republic of Ireland.
Davey MG; Department of Surgery, National University of Ireland, Galway, H91YR71, Republic of Ireland. .
Moloney BM; Department of Surgery, National University of Ireland, Galway, H91YR71, Republic of Ireland.
Barry MK; Department of Surgery, National University of Ireland, Galway, H91YR71, Republic of Ireland.
Sweeney K; Department of Surgery, National University of Ireland, Galway, H91YR71, Republic of Ireland.
McLaughlin RP; Department of Surgery, National University of Ireland, Galway, H91YR71, Republic of Ireland.
Malone CM; Department of Surgery, National University of Ireland, Galway, H91YR71, Republic of Ireland.
Lowery AJ; Department of Surgery, National University of Ireland, Galway, H91YR71, Republic of Ireland.
Kerin MJ; Department of Surgery, National University of Ireland, Galway, H91YR71, Republic of Ireland.
Pokaż więcej
Źródło:
Irish journal of medical science [Ir J Med Sci] 2022 Dec; Vol. 191 (6), pp. 2501-2510. Date of Electronic Publication: 2022 Jan 25.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/diagnosis
Triple Negative Breast Neoplasms*/metabolism
Humans ; Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Female ; Neoplasm Recurrence, Local ; Retrospective Studies ; Receptor, ErbB-2/metabolism ; Breast/pathology ; Kaplan-Meier Estimate ; Receptors, Progesterone/metabolism ; Prognosis ; Biomarkers, Tumor/metabolism
Czasopismo naukowe
Tytuł:
Residual Cancer Burden Class Associated with Survival Outcomes in Women with Different Phenotypic Subtypes of Breast Cancer After Neoadjuvant Chemotherapy.
Autorzy:
Elder EA; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA.
Livasy CA; Department of Pathology, Levine Cancer Institute, Charlotte, NC, USA.
Donahue EE; Department of Cancer Biostatistics, Levine Cancer Institute, Charlotte, NC, USA.
Neelands B; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA.; Clinical Trials Department, Levine Cancer Institute, Charlotte, NC, USA.
Patrick A; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA.; Clinical Trials Department, Levine Cancer Institute, Charlotte, NC, USA.
Needham M; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA.; Clinical Trials Department, Levine Cancer Institute, Charlotte, NC, USA.
Sarantou T; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA.
Hadzikadic-Gusic L; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA.
Heeke AL; Department of Medical Oncology, Levine Cancer Institute, Charlotte, NC, USA.
White RL Jr; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA. .
Pokaż więcej
Źródło:
Annals of surgical oncology [Ann Surg Oncol] 2022 Dec; Vol. 29 (13), pp. 8060-8069. Date of Electronic Publication: 2022 Aug 18.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/drug therapy
Humans ; Female ; Neoadjuvant Therapy ; Neoplasm, Residual/drug therapy ; Receptor, ErbB-2/metabolism ; Prognosis ; Retrospective Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Chemotherapy, Adjuvant
Czasopismo naukowe
Tytuł:
Neoadjuvant systemic therapy in geriatric breast cancer patients: a National Cancer Database (NCDB) analysis.
Autorzy:
Brown L; USF Health Morsani College of Medicine, 12901 Bruce B Downs Blvd, Tampa, FL, 33612, USA.
Naffouje SA; Department of Surgical Oncology, Moffitt Cancer Center, 12902 N. McKinley Drive, Tampa, FL, 33612, USA.
Sam C; Senior Adult Oncology Program, Moffitt Cancer Center, 12902 N. McKinley Drive, Tampa, FL, 33612, USA.
Laronga C; Comprehensive Breast Program, Moffitt Cancer Center, 12902 N. McKinley Drive, Tampa, FL, 33612, USA.
Catherine Lee M; Comprehensive Breast Program, Moffitt Cancer Center, 12902 N. McKinley Drive, Tampa, FL, 33612, USA. .
Pokaż więcej
Źródło:
Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Dec; Vol. 196 (3), pp. 441-451. Date of Electronic Publication: 2022 Oct 08.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Breast Neoplasms*/drug therapy
Breast Neoplasms*/epidemiology
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/epidemiology
Carcinoma, Ductal, Breast*/therapy
Aged, 80 and over ; Humans ; Female ; Aged ; Neoadjuvant Therapy/methods ; Databases, Factual ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Disease Behavior and Treatment Response of Special Histological Types of Triple-Negative Breast Cancer.
Autorzy:
Bonadio RC; Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil; Instituto D'Or de Pesquisa e Ensino (IDOR), São Paulo, Brazil. Electronic address: .
Costa FA; Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil.
Mendes SV; Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil.
Araujo BJ; Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil.
Nader-Marta G; Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B).
Pinto PBC; Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil; AC Camargo Cancer Center, São Paulo, Brazil.
Batista DN; Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil; Instituto D'Or de Pesquisa e Ensino (IDOR), São Paulo, Brazil.
Testa L; Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil; Instituto D'Or de Pesquisa e Ensino (IDOR), São Paulo, Brazil.
Ferrari MS; Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil.
Pokaż więcej
Źródło:
Clinical breast cancer [Clin Breast Cancer] 2022 Dec; Vol. 22 (8), pp. e892-e900. Date of Electronic Publication: 2022 Aug 20.
Typ publikacji:
Journal Article
MeSH Terms:
Triple Negative Breast Neoplasms*/therapy
Triple Negative Breast Neoplasms*/pathology
Carcinoma, Lobular*/pathology
Carcinoma, Ductal, Breast*/pathology
Breast Neoplasms*/pathology
Humans ; Female ; Prognosis ; Neoadjuvant Therapy ; Metaplasia
Czasopismo naukowe
Tytuł:
Matrix metalloproteinase 2 is a target of the RAN-GTP pathway and mediates migration, invasion and metastasis in human breast cancer.
Autorzy:
El-Tanani M; Pharmacological and Diagnostic Research Centre, Al-Ahliyya Amman University, Faculty of Pharmacy, Amman, Jordan; Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, Bradford, UK. Electronic address: .
Platt-Higgins A; Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
Lee YF; Neuroscience, Psychology & Behaviour, College of Life Sciences, University of Leicester, Leicester LE1 9HN, UK; School of Life Sciences, Faculty of Science and Engineering, Anglia Ruskin University, Cambridge CB1 1PT, UK.
Al Khatib AO; Pharmacological and Diagnostic Research Centre, Al-Ahliyya Amman University, Faculty of Pharmacy, Amman, Jordan.
Haggag Y; Department of Pharmaceutical Technology, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
Sutherland M; School of Chemistry and Biomedical Sciences, University of Bradford, Bradford, UK.
Zhang SD; Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, Bradford, UK; Northern Ireland Centre for Stratified Medicine, Biomedical Sciences, University of Ulster, UK.
Aljabali AAA; Department of Pharmaceutics and Pharmaceutical Technology, Yarmouk University, Irbid, Jordan.
Mishra V; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, Punjab, India.
Serrano-Aroca Á; Biomaterials and Bioengineering Lab, Centro de Investigación Traslacional San Alberto Magno, 16 Universidad Católica de Valencia San Vicente Mártir, c/Guillem de Castro 94, 46001, Valencia, Spain.
Tambuwala MM; School of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine BT52 1SA, UK. Electronic address: .
Rudland PS; Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
Pokaż więcej
Źródło:
Life sciences [Life Sci] 2022 Dec 01; Vol. 310, pp. 121046. Date of Electronic Publication: 2022 Oct 06.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Matrix Metalloproteinase 2*/metabolism
ran GTP-Binding Protein*/genetics
ran GTP-Binding Protein*/metabolism
Triple Negative Breast Neoplasms*/pathology
Female ; Humans ; Cell Line, Tumor ; Cell Movement ; Gene Expression Regulation, Neoplastic ; Guanosine Triphosphate ; Neoplasm Invasiveness
Czasopismo naukowe
Tytuł:
Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.
Autorzy:
Musall BC; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Adrada BE; Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Candelaria RP; Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Mohamed RMM; Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Abdelhafez AH; Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Son JB; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Sun J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Santiago L; Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Whitman GJ; Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Moseley TW; Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Scoggins ME; Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Mahmoud HS; Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
White JB; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Hwang KP; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Elshafeey NA; Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Boge M; Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Zhang S; Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Litton JK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Valero V; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Thompson AM; Division of Surgical Oncology, Baylor College of Medicine, Houston, Texas, USA.
Yam C; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Wei P; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Moulder SL; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pagel MD; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Yang WT; Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Ma J; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Rauch GM; Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło:
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2022 Dec; Vol. 56 (6), pp. 1901-1909. Date of Electronic Publication: 2022 May 02.
Typ publikacji:
Journal Article
MeSH Terms:
Triple Negative Breast Neoplasms*/diagnostic imaging
Triple Negative Breast Neoplasms*/drug therapy
Breast Neoplasms*
Humans ; Female ; Neoadjuvant Therapy ; Prospective Studies ; Retrospective Studies ; Diffusion Magnetic Resonance Imaging/methods
Czasopismo naukowe
Tytuł:
MRI characteristics of breast edema for assessing axillary lymph node burden in early-stage breast cancer: a retrospective bicentric study.
Autorzy:
Xu Z; School of Medicine, South China University of Technology, Guangzhou, 510006, China.; Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Ding Y; Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunzhou road, Kunming, 650118, China.
Zhao K; Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.; Guangdong Cardiovascular Institute, Guangzhou, 510080, China.
Han C; Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.; Guangdong Cardiovascular Institute, Guangzhou, 510080, China.
Shi Z; Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.; Guangdong Cardiovascular Institute, Guangzhou, 510080, China.
Cui Y; Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.; Guangdong Cardiovascular Institute, Guangzhou, 510080, China.
Liu C; Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.
Lin H; School of Medicine, South China University of Technology, Guangzhou, 510006, China.; Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Pan X; Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.; Guangdong Cardiovascular Institute, Guangzhou, 510080, China.
Li P; Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China.
Chen M; Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.; Shantou University Medical College, Shantou, 515063, China.
Wang H; Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.; Shantou University Medical College, Shantou, 515063, China.
Deng X; Department of Information Management, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.
Liang C; Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Xie Y; Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunzhou road, Kunming, 650118, China. fish_.
Liu Z; School of Medicine, South China University of Technology, Guangzhou, 510006, China. .; Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China. .; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China. .
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2022 Dec; Vol. 32 (12), pp. 8213-8225. Date of Electronic Publication: 2022 Jun 15.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/complications
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/pathology
Breast Diseases*/pathology
Humans ; Female ; Retrospective Studies ; Lymphatic Metastasis/pathology ; Axilla/pathology ; Lymph Nodes/diagnostic imaging ; Lymph Nodes/pathology ; Magnetic Resonance Imaging/methods ; Edema/diagnostic imaging ; Edema/pathology
Czasopismo naukowe
Tytuł:
Screening brain MRI in inflammatory breast cancer: Is it time?
Autorzy:
Dhakal A; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA.
Anders CK; Duke Cancer Institute, Duke University Health System, Durham, North Carolina, USA.
Pokaż więcej
Źródło:
Cancer [Cancer] 2022 Dec 01; Vol. 128 (23), pp. 4055-4057. Date of Electronic Publication: 2022 Oct 10.
Typ publikacji:
Editorial
MeSH Terms:
Inflammatory Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/diagnostic imaging
Humans ; Female ; Early Detection of Cancer ; Mass Screening ; Magnetic Resonance Imaging ; Brain/diagnostic imaging ; Mammography ; Breast/diagnostic imaging
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz